Crossref
FDA Approves Hypertriglyceridemia Drug That May Reduce Pancreatitis Risk
JAMA · 11.08.2026 · 336 (6) · 453
DOI: 10.1001/jama.2026.9480 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 11.08.2026. Verfasst von Samantha Anderer.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Anderer, S. (2026). FDA Approves Hypertriglyceridemia Drug That May Reduce Pancreatitis Risk. JAMA, 336(6), 453. https://doi.org/10.1001/jama.2026.9480
Vancouver
Anderer S. FDA Approves Hypertriglyceridemia Drug That May Reduce Pancreatitis Risk. JAMA. 2026;336(6):453. doi:10.1001/jama.2026.9480
BibTeX
@article{Anderer2026,
author = {Anderer, Samantha},
title = {FDA Approves Hypertriglyceridemia Drug That May Reduce Pancreatitis Risk},
journal = {JAMA},
year = {2026},
volume = {336},
number = {6},
pages = {453},
doi = {10.1001/jama.2026.9480}
}
EUVIMED